DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 45 filers reported holding DENALI THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150,371,245 | -27.6% | 7,288,960 | +3.6% | 0.03% | -23.1% |
| Q2 2023 | $207,696,573 | +73.3% | 7,038,176 | +35.3% | 0.04% | +62.5% |
| Q1 2023 | $119,818,599 | -15.9% | 5,200,460 | +1.5% | 0.02% | -17.2% |
| Q4 2022 | $142,435,312 | +21286.7% | 5,121,730 | +23509.0% | 0.03% | – |
| Q3 2022 | $666,000 | +192.1% | 21,694 | +49.0% | 0.00% | – |
| Q4 2017 | $228,000 | – | 14,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |